Surrogate markers for breast T-ICs (CD44+/CD24−, ALDH1+ and SP) were determined by fluorescence-activated cell sorting in a panel of cultured BC cells with luminal (Lu) or basal (B) global transcriptome expression profiles (Neve et al, 2006). Here, CD44 is linked to breast cancer.